References
- Vartia KO. Antibiotics in lichens. In: Ahmadjian V, Hale ME, eds. The Lichens, 3rd ed. New York: Academic Press, 1973:547–61.
- Hale ME. The Biology of Lichens. London: Edward Arnold, 1983.
- Ingolfsdottir K, Bloomfield SF, Hylands PJ. In vitro evaluation of the antimicrobial activity of lichen metabolites as potential preservatives. Antimicrob Agents Chemother 1985;28:289–92.
- Sankawa U, Shibuya M, Ebizuka Y, Noguchi H, Kinoshita T, Iitaka Y, et al. Depside as potent inhibitor of prostaglandin biosynthesis: a new active site model for fatty acid cyclooxygenase. Prostoglandins 1982;24:21–34.
- Proksa B, Adamcova J, Sturdikova M, Fuska J.Metabolites of Pseudevernia furfuracea (L.) Zopf. and their inhibition potential of prototypic enzymes. Pharmazie 1994;49:282–3.
- Yamamoto Y, Miura Y, Kinoshita Y, Higuchi M, Yamada Y, Murakami A, et al. Screening of tissue cultures and thalli of lichens and some of their active constituents for inhibition of tumor-promoter-induced Epstein-Barr virus activation. Chem Pharm Bull 1995;43:1388–90.
- Kumar KCS, Muller K.Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth. J Nat Prod 1999;62:821–3.
- Nielsen J, Nielsen PH, Frisvad JC. Fungal depside, guisinol, from a marine derived strain of Emericella ungui. Phytochemistry 1998;50:263–5.
- Neamati N, Hong HX, Mazumder A, Wang SM, Sunder S, Nicklaus M, et al. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J Med Chem 1997;40:942–51.
- Kumar KCS, Muller K.Depsides as non-redox inhibitors of leukotriene B4 biosynthesis and HaCaT cell growth, 2. Novel analogues of obtusatic acid. Eur J Med Chem 2000;35:405–11.
- Lindenmeyer MT, Hrenn A, Kern C, Castro V, Murillo R, Muller S, et al. Sesquiterpene lactones as inhibitors of IL-8 expression in HeLa cells. Bioorg Med Chem 2006;14:2487–97.
- Attwood MR, Conway EA, Dunsdon RM, Greening JR, Handa BK, Jones PS, et al. Peptide based inhibitors of interleukin-8: structural simplification and enhanced potency. Bioorg Med Chem Lett 1997;7:429–32.
- Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature (London) 1993;365:654–7.
- Koch AE, Kunkel SE, Burrows JC, Evanoff HL, Haines GK, Pope RM, et al. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Immunol 1991;147:2187–95.
- Mulligan MS, Jones ML, Bolanski MA, Baganoff MP, Deppeler CL, Meyers DM, et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993;150:5585–95.
- Reynertson KA, Wallace AM, Adachi S, Gil RR, Yang H, Basile MJ, et al. Bioactive depsides and anthocyanins from jaboticaba (Myrciaria cauliflora). J Nat Prod 2006;69:1228–30.
- Dentener MA, Bazil V, Asmuth EJ, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993;150:2885–91.
- Brauner A, Soederhaell M, Jacobson SH, Lundahl J, Andersson U, Andersson J. Escherichia coli-induced expression of IL-1 [alpha], IL-1 [beta], IL-6 and IL-8 in normal human renal tubular epithelial cells. Clin Exp Immunol 2001;124, 423–8.
- Lammers KM, Helwig U, Swennen E, Rizzello F, Venturi A, Caramelli E, et al. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 2002;97:1182–6.